Skip to main content
Yabao Pharmaceutical Group Co.,Ltd logo

Yabao Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 600351 ISIN · CNE000001CM5 LEI · 65560071PKRS4UHMVU53 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,361 across all filing types
Latest filing 2023-10-27 Governance Information
Country CN China
Listing Shanghai Stock Exchange 600351

About Yabao Pharmaceutical Group Co.,Ltd

http://www.yabao.com.cn

Yabao Pharmaceutical Group Co.,Ltd. focuses on the research, development, manufacturing, and commercialization of pharmaceutical products. The company maintains a specialized portfolio across therapeutic areas including pediatrics, cardiovascular health, and endocrinology. Key offerings include traditional Chinese medicines, chemical drugs, and innovative transdermal patches, such as the Dinggui Erqi Patch. The organization operates integrated production bases and research facilities dedicated to advancing drug delivery systems and biotechnological applications. Its business model emphasizes the modernization of traditional therapies alongside the development of conventional pharmaceuticals to address diverse clinical needs.

Recent filings

Filing Released Lang Actions
董事会薪酬与考核委员会工作细则
Governance Information Classification · 95% confidence The document is titled as the "Board of Directors' Remuneration and Assessment Committee Working Rules" for a company, detailing the structure, responsibilities, and procedures of the remuneration and assessment committee. It focuses on governance practices related to board and senior management compensation and performance evaluation. There are no financial statements, earnings data, or regulatory filings mentioned. The content is about internal governance rules and committee operations, which aligns with Governance Information filings. The document length is 2587 characters, which is relatively short but contains substantive governance content, not just an announcement or summary. Therefore, the appropriate classification is Governance Information (CGR).
2023-10-27 Chinese
亚宝药业集团股份有限公司董事会议事规则
Governance Information Classification · 100% confidence The document is titled "亚宝药业集团股份有限公司 董事会议事规则 (2023 年10 月修订)" which translates to "Rules of Procedure for the Board of Directors of Yabao Pharmaceutical Group Co., Ltd. (Revised October 2023)". The content details the procedures, rules, and governance practices for board meetings, including meeting types, proposal submission, voting procedures, meeting records, and confidentiality. There is no financial data, no audit information, no earnings or capital updates, no voting results, no legal proceedings, and no announcements of reports. The document is a governance document outlining internal rules and board structure. Therefore, it fits the category of Governance Information (CGR). The document length is over 5,000 characters and contains detailed governance rules, not just an announcement or summary, so it is not RPA or RNS.
2023-10-27 Chinese
亚宝药业集团股份有限公司关于修订《公司章程》的公告
Governance Information Classification · 95% confidence The document is an announcement regarding amendments to the company's Articles of Association (公司章程). It details specific changes to the company's internal governance rules, board structure, and procedures. The document is issued by the board and references compliance with regulatory requirements and internal control improvements. It does not contain financial statements or performance data, nor is it a report of voting results or a proxy solicitation. The focus on company governance and internal rules aligns with the definition of Governance Information (CGR). The document length is short and it is not merely announcing a report publication but providing substantive governance changes. Therefore, the appropriate classification is Governance Information (CGR).
2023-10-27 Chinese
董事会提名委员会工作细则
Governance Information Classification · 95% confidence The document is titled '董事会提名委员会工作细则' which translates to 'Board Nomination Committee Working Rules'. It details the structure, responsibilities, procedures, and rules governing the nomination committee of the board of directors. There is no financial data, no mention of financial results, no regulatory filings or announcements, and no indication of a report or meeting materials. The content focuses on governance practices related to board nominations and management appointments, which aligns with governance information about internal rules and board structure. Therefore, the document fits best under Governance Information (CGR). The document length is 2311 characters, which is relatively short but contains substantive governance content, not just an announcement or notice.
2023-10-27 Chinese
亚宝药业集团股份有限公司关于全资子公司获得药品补充申请批准通知书的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by 亚宝药业集团股份有限公司 regarding its wholly-owned subsidiary receiving an official approval notice from the National Medical Products Administration for a drug supplement application. The content focuses on regulatory approval details, drug specifications, and risk warnings. It does not contain financial statements, management discussion, or detailed financial data. The document length is short (1315 characters) and is an announcement of an approval notice rather than a full report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-10-18 Chinese
亚宝药业集团股份有限公司关于以集中竞价交易方式回购股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement regarding the progress of a share repurchase program by the company 亚宝药业集团股份有限公司. It details the number of shares repurchased, the price range, total amount spent, and compliance with relevant regulations. There is no financial statement or comprehensive financial data presented, nor is it a report or presentation. The content fits the description of a Transaction in Own Shares (POS) filing, which reports on the company's buyback activities.
2023-10-09 Chinese

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.